Bellevue Life Sciences Ac... (BLAC)
NASDAQ: BLAC
· Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM
Bellevue Life Sciences Acquisition Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -2.41M | -474.86K | -165.71K | 233.04K | 403.78K | 475.7K | 377.5K | 75.04K | -35.39K | -21.46K | -1.55K | -567 | -441 | -119 |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 1.02M | 1.04M | 1.56M | 978.81K | 256.67K | 117.26K | -43.96K | 37.11K | 24.01K | 5.49K | 5.49K | 5.49K | 5.29K |
Other Non-Cash Items | 222.93K | -2.23M | -2.49M | -2.84M | -2.78M | -1.85M | -1.23M | -417.73K | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 735.44K | 778.42K | 1.79M | 1.55M | 830.6K | 457.33K | 290.15K | 31.15K | 18.05K | -465 | 5.49K | 5.49K | 5.29K |
Operating Cash Flow | -2.19M | -1.96M | -1.88M | -812.12K | -818.77K | -540.23K | -393.21K | -52.53K | -4.24K | -3.4K | -2.02K | 4.93K | 5.05K | 5.17K |
Capital Expenditures | n/a | n/a | -2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -180K | -460K | -300K | -70.39M | -70.21M | -70.21M | -70.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 36.56M | 36.56M | 36.56M | 36.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 35.79M | 53.19M | 53.62M | 36.26M | -33.83M | -70.21M | -70.21M | -70.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 35.91M | 53.31M | 53.46M | 36.26M | -33.83M | -70.21M | -70.21M | -70.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | 1.63M | 1.55M | 190K | -1.15M | -700K | -907K | -507K | 793K | 503K | 610K | 210K | 110K | 100K |
Common Stock Repurchased | n/a | n/a | -17.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.18M | 15K | 25K | 15K | 7.71M | 7.47M | 7.47M | 7.14M | -659.89K | -430.63K | -543.93K | -208.66K | -120.42K | -106.3K |
Financial Cash Flow | -33.67M | -51.39M | -51.46M | -35.79M | 34.54M | 70.74M | 70.53M | 70.59M | 123.98K | 63.24K | 66.07K | 1.34K | -10.42K | -6.3K |
Net Cash Flow | 50.72K | -45.72K | 117.94K | -345.17K | -109.08K | -10.88K | -72.99K | 332.41K | 119.74K | 59.83K | 58.75K | 970.00 | -10.66K | -6.42K |
Free Cash Flow | -2.19M | -1.96M | -1.88M | -812.12K | -818.77K | -540.23K | -393.21K | -52.53K | -4.24K | -3.4K | -2.02K | 4.93K | 5.05K | 5.17K |